Cargando…
Selection of data sets for FAIRification in drug discovery and development: Which, why, and how?
Despite the intuitive value of adopting the Findable, Accessible, Interoperable, and Reusable (FAIR) principles in both academic and industrial sectors, challenges exist in resourcing, balancing long- versus short-term priorities, and achieving technical implementation. This situation is exacerbated...
Autores principales: | Alharbi, Ebtisam, Gadiya, Yojana, Henderson, David, Zaliani, Andrea, Delfin-Rossaro, Alejandra, Cambon-Thomsen, Anne, Kohler, Manfred, Witt, Gesa, Welter, Danielle, Juty, Nick, Jay, Caroline, Engkvist, Ola, Goble, Carole, Reilly, Dorothy S., Satagopam, Venkata, Ioannidis, Vassilios, Gu, Wei, Gribbon, Philip |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science Ltd. ;, Distributed by Virgin Mailing and Distribution
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9236643/ https://www.ncbi.nlm.nih.gov/pubmed/35595012 http://dx.doi.org/10.1016/j.drudis.2022.05.010 |
Ejemplares similares
-
FAIR in action - a flexible framework to guide FAIRification
por: Welter, Danielle, et al.
Publicado: (2023) -
Diabetes, inflammation, and the adiponectin paradox: Therapeutic targets in SARS-CoV-2
por: Ho, Gilbert, et al.
Publicado: (2021) -
The PI3K/Akt/mTOR pathway: A potential pharmacological target in COVID-19
por: Basile, Maria Sofia, et al.
Publicado: (2022) -
Myotonic dystrophy type 1 drug development: A pipeline toward the market
por: Pascual-Gilabert, Marta, et al.
Publicado: (2021) -
Integrating heterogeneous data to facilitate COVID-19 drug repurposing
por: Prieto Santamaría, Lucía, et al.
Publicado: (2022)